Donor and transplant characteristics
| Characteristics . | No. of patients . |
|---|---|
| Donor age, y; range (median) | 15-71 (42) |
| Donor gender, M/F | 42/67 |
| Donor CMV serology | |
| CMV+ | 48 |
| CMV− | 61 |
| Donor/patient relationship | |
| Related | |
| HLA-identical sibling | 41 |
| HLA-nonidentical* | 3 |
| Syngeneic† | 1 |
| Unrelated | |
| HLA-identical | 53 |
| HLA-nonidentical | 11 |
| Source of stem cells | |
| Marrow | 81 |
| Peripheral blood‡ | 28 |
| GVHD prophylaxis | |
| MTX + CSP | 97 |
| MMF + CSP | 6 |
| MTX + FK506 | 5 |
| None2-153 | 1 |
| Characteristics . | No. of patients . |
|---|---|
| Donor age, y; range (median) | 15-71 (42) |
| Donor gender, M/F | 42/67 |
| Donor CMV serology | |
| CMV+ | 48 |
| CMV− | 61 |
| Donor/patient relationship | |
| Related | |
| HLA-identical sibling | 41 |
| HLA-nonidentical* | 3 |
| Syngeneic† | 1 |
| Unrelated | |
| HLA-identical | 53 |
| HLA-nonidentical | 11 |
| Source of stem cells | |
| Marrow | 81 |
| Peripheral blood‡ | 28 |
| GVHD prophylaxis | |
| MTX + CSP | 97 |
| MMF + CSP | 6 |
| MTX + FK506 | 5 |
| None2-153 | 1 |
Includes one patient with an HLA-phenotypically matched donor.
For the purpose of this analysis, the patient was included in the group receiving transplants from HLA-identical siblings.
Nineteen HLA-identical siblings, 6 HLA-identical unrelated donors, and 3 HLA-nonidentical donors.
One patient received a syngeneic transplant.